Twice daily cefpodoxime proxetil compared with thrice daily amoxicillin/clavulanic acid for treatment of acute otitis media in children.

A total of 260 children, 3 months to 11 years old (median age 24 months), with acute otitis media (AOM) received either cefpodoxime proxetil (CP) 8 mg/kg/d b.i.d. or amoxicillin/clavulanic acid (ACA) 40/10 mg/kg/d t.i.d. for 8 days. A significant difference in clinical cure rates was observed between the CP group 71/118 (60%) and the ACA group 42/105 (40%), p = 0.003. At the follow-up visit (20-30 days after the start of treatment), significant advantages were recorded with the CP vs. ACA therapy, in terms of satisfactory clinical response [90/111 (81%) vs 60/94 (63.8%), p = 0.005] residual middle ear effusion (14.4% vs 28.7%, p = 0.01) and normal tympanometry (78% vs 61.4%, p = 0.017). Compliance and adverse event frequency were the same in both treatment groups. The higher clinical cure rate and equivalent safety profile of CP indicates that it is an acceptable alternative to ACA for the treatment of AOM in children.

[1]  P. Berche,et al.  Comparative efficacy and safety of cefprozil and amoxycillin/clavulanate in the treatment of acute otitis media in children. , 1994, The Journal of antimicrobial chemotherapy.

[2]  C. Kunin.  Guidelines for the evaluation of new anti-infective drugs for the treatment of urinary tract infection: additional considerations. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  M. D. Del Beccaro,et al.  Cefpodoxime proxetil compared with amoxicillin-clavulanate for the treatment of otitis media. , 1992, The Journal of pediatrics.

[4]  J. Nelson,et al.  Comparative evaluation of loracarbef and amoxicillin-clavulanate for acute otitis media , 1991, Antimicrobial Agents and Chemotherapy.

[5]  A. Tomasz,et al.  Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary. , 1991, The Journal of infectious diseases.

[6]  F. Baquero,et al.  A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. , 1991, The Journal of antimicrobial chemotherapy.

[7]  K. Klugman.  Pneumococcal resistance to antibiotics , 1990, Clinical Microbiology Reviews.

[8]  H. Sakata,et al.  [Overall clinical evaluation of cefpodoxime proxetil against infections in pediatric fields]. , 1989, The Japanese journal of antibiotics.

[9]  B Rosner,et al.  Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. , 1989, The Journal of infectious diseases.

[10]  F. Abe,et al.  In vitro immunosuppressive properties of spergualins to murine T cell response. , 1989, The Journal of antibiotics.

[11]  G. Giebink,et al.  The microbiology of otitis media , 1989, The Pediatric infectious disease journal.

[12]  C. Bluestone.  Pathogenesis of otitis media related to vaccine efficacy , 1989, The Pediatric infectious disease journal.

[13]  C. Bluestone.  Management of otitis media in infants and children: current role of old and new antimicrobial agents , 1988, The Pediatric infectious disease journal.

[14]  H. Neu,et al.  In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746 , 1988, Antimicrobial Agents and Chemotherapy.

[15]  H. Sørensen.  Management of postoperative laryngeal edema following laryngoscopy for procedures as simple as biopsy of a tumor. , 1987 .

[16]  J. Williams,et al.  Resistance of clinical isolates of Haemophilus influenzae in United Kingdom 1986. , 1987, British medical journal.

[17]  J. Pukander,et al.  Incidence of acute otitis media up to the age of 1 1/2 years in urban infants. , 1987, Acta oto-laryngologica.

[18]  O. Ruuskanen,et al.  Finnish Approach to the Treatment of Acute Otitis Media Report of the Finnish Consensus Conference , 1987, The Annals of otology, rhinology & laryngology. Supplement.

[19]  R. Battmer,et al.  Overview of the Hannover Program Using the Nucleus Device , 1987 .

[20]  G. V. Van Hare,et al.  A randomized controlled trial of amoxicillin plus clavulanate compared with cefaclor for treatment of acute otitis media. , 1986, The Journal of pediatrics.

[21]  G. Gates.  Otologic referral: indications and expectations , 1986, Pediatric infectious disease.

[22]  J. Nelson,et al.  Comparative treatment trial of augmentin versus cefaclor for acute otitis media with effusion. , 1985, Pediatrics.

[23]  G. V. Van Hare,et al.  Emergence of beta-lactamase-producing strains of Branhamella catarrhalis as important agents of acute otitis media. , 1983, Pediatric infectious disease.

[24]  H. Koornhof,et al.  Emergence of multiply resistant pneumococci. , 1978, The New England journal of medicine.